logo

For the Inventor, By the Inventor

Englewood, CO, United States of America

Ampio Pharmaceuticals, Inc.


USPTO Granted Patents = 37

% Expired Patents = 73.0



Trademarks = 1

Forward Citations = 192

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal David Bar-Or (37 out of 101 patents)

silverMedal Raphael Bar-Or (7 out of 34 patents)

bronzeMedal Richard Shimonkevitz (6 out of 10 patents)

4.  Greg Thomas (6 out of 10 patents)

5.  James V Winkler (5 out of 11 patents)

6.  Nagaraja K R Rao (5 out of 12 patents)

7.  C Gerald Curtis (4 out of 9 patents)

8.  Holli Cherevka (2 out of 2 patents)

9.  Leonard T Rael (1 out of 13 patents)

10.  Nagaraja K Rao (0 patent)

11.  C Gerald Curtis (0 patent)


Core Competencies:
N-Acetyl Kynurenine
T-Cell Mediated Diseases
Respiratory Viruses
Joint Conditions
Stem Cells
Implantable Devices
Diketopiperazines
Therapeutic Compounds
Immune Tolerance
Degenerative Joint Disease
Disease Treatment
Medical Methods

37 patents:

1. 11478441 - Treatment of disease with n-acetyl kynurenine (2022-10-25),
2. 11369598 - Treatment of T-cell mediated diseases (2022-06-28),
3. 11278598 - Methods for treating diseases associated with respiratory viruses (2022-03-22),
4. 11129878 - Methods for treating diseases associated with respiratory viruses (2021-09-28),
5. 11090301 - Treatment of joint conditions (2021-08-17),
6. 11058798 - Implantable medical devices with increased immune tolerance, and methods for making and implanting (2021-07-13),
7. 11026940 - Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same (2021-06-08),
8. 10881710 - Treatment of rhinitis (2021-01-05),
9. 10842847 - Treatment of degenerative joint disease (2020-11-24),
10. 10828296 - Treatment of T-cell mediated diseases (2020-11-10),
11. 10471178 - Implantable medical devices with increased immune tolerance, and methods for making and implanting (2019-11-12),
12. 10342793 - Treatment of joint conditions (2019-07-09),
13. 10251930 - Treatment of degenerative joint disease (2019-04-09),
14. 10058562 - Methods of treatment of diseases (2018-08-28),
15. 10039760 - Method of using diketopiperazines and composition containing them (2018-08-07),
Company Overview
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company based in Englewood, Colorado, focused on developing innovative therapies for various medical conditions. The company specializes in the research and development of treatments that leverage its proprietary drug delivery systems and biologics. Ampio's primary research domains include regenerative medicine and the treatment of inflammatory diseases, aiming to address unmet medical needs through advanced therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Ampio Pharmaceuticals, Inc. USPTO Patent Assignee Logo
37 Patents

#17 in Englewood, CO

#190 in Colorado

#9,262 in US

#18,281 in the World

Englewood, CO (US)
Englewood, CO, United States of America

Ampio Pharmaceuticals, Inc.

Forward Citations = 192

9 inventors:

goldMedal David Bar-Or (37 out of 101 patents)

silverMedal Raphael Bar-Or (7 out of 34 patents)

bronzeMedal Richard Shimonkevitz (6 out of 10 patents)

4.  Greg Thomas (6 out of 10 patents)

5.  James V Winkler (5 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ampio Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/ampio-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…